Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|7-1048|2|370-372

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.2, 1996-08, pp. : 370-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 370-372

John Wiley & Sons Inc

Access to resources Recommend Favorite

A derivative of epigallocatechin‐3‐gallate induces apoptosis via SHP‐1‐mediated suppression of BCR‐ABL and STAT3 signalling in chronic myelogenous leukaemia

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3565-3578

John Wiley & Sons Inc

Access to resources Recommend Favorite

BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work?

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 212-217

Karger

Access to resources Recommend Favorite

Detection of the BCR-ABL Fusion Gene in Natural Killer Cells in Patients with Chronic Myelogenous Leukemia

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-07 ,pp. : 11-16

Karger

Access to resources Recommend Favorite